Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Abigail L Gee"'
Autor:
Avinash Aujayeb, Rachel Prichard, S Park, Mark A Baxter, J Hamilton, H Ali, L Hannington, Conor O'Neill, J Platt, G Clements, Deborah Scott, R Heywood, Helen Dearden, Sally Martin, Michael Rowe, Kieran Zucker, Clair Brunner, Adam L Peters, Maria Rohan, Alexandra Marsh, Abigail L Gee, Gemma Quesne, Jonny Heseltine, Joni Howells, Veronica Conteh, Xiangfei Yan, Lisa J Rodgers, J Grech, S McInerney, S Kingdon, L Eastlake, R Bryce, D Parslow, V Cope, N Aziz
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective The Cancer and Aging Research Group (CARG) score was developed to predict severe chemotherapy-induced toxicity risk in older adults; validation study results have varied. The Tolerance of Anti-cancer Systemic Therapy in the Elderly study so
Externí odkaz:
https://doaj.org/article/30744de9a2794c768c87e2ba9b482a00
Autor:
Nicolò Matteo Luca Battisti, Laura Morrison, Tamsin Nash, Nishanti Senthivel, Samantha Kestenbaum, Parvin Begum, Mariam Obeid, William Hayhurst, Dorothy Yang, Shafiah Gafoor, Caroline Brown, Farah Rehman, Laura Kenny, Olivia Hatcher, Susan Susan, Jennet Williams, Anna Brown, Hamoun Rozati, Alexandros Alexandros, Elinor Sawyer, Charalampos Gousis, Eleni Karapanagiotou, Anna Rigg, Kleopatra Rapti, Rebecca Roylance, Mark Beresford, Abigail L Gee, Apostolos Konstantis, Judy King, Mark Nathan, Emma Spurrell, Mark Pearce, Dane Bradwell, Arshi Denton, Kate Swain, Sophie McGrath, Mark Allen, Alistair Ring, Stephen Johnston, Fharat Raja
Publikováno v:
Cancer Research. 82:P1-17
Background Abemaciclib is approved in 1st and 2nd line for hormone receptor (HR)-positive HER2-negative advanced breast cancer (ABC). However, outcomes on this agent are unclear in the real world.We determined the safety and efficacy profile of abema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46078e8a48bea41baf70095f039369ae
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08